ID GPR34_HUMAN Reviewed; 381 AA. AC Q9UPC5; O95853; DT 24-JAN-2001, integrated into UniProtKB/Swiss-Prot. DT 24-JAN-2001, sequence version 2. DT 27-MAR-2024, entry version 172. DE RecName: Full=Probable G-protein coupled receptor 34; GN Name=GPR34; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Fetal brain; RX PubMed=10395919; DOI=10.1016/s0167-4781(99)00081-0; RA Schoneberg T., Schulz A., Grosse R., Schade R., Henklein P., Schultz G., RA Gudermann T.; RT "A novel subgroup of class I G-protein-coupled receptors."; RL Biochim. Biophys. Acta 1446:57-70(1999). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=10036181; DOI=10.1006/geno.1998.5655; RA Marchese A., Sawzdargo M., Nguyen T., Cheng R., Heng H.H.Q., Nowak T., RA Im D.-S., Lynch K.R., George S.R., O'Dowd B.F.; RT "Discovery of three novel orphan G-protein-coupled receptors."; RL Genomics 56:12-21(1999). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=10982042; DOI=10.1007/s004390000337; RA Jacobi F.K., Broghammer M., Pesch K., Zrenner E., Berger W., Meindl A., RA Pusch C.M.; RT "Physical mapping and exclusion of GPR34 as the causative gene for RT congenital stationary night blindness type 1."; RL Hum. Genet. 107:89-91(2000). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=16460680; DOI=10.1016/j.bbrc.2006.01.069; RA Sugo T., Tachimoto H., Chikatsu T., Murakami Y., Kikukawa Y., Sato S., RA Kikuchi K., Nagi T., Harada M., Ogi K., Ebisawa M., Mori M.; RT "Identification of a lysophosphatidylserine receptor on mast cells."; RL Biochem. Biophys. Res. Commun. 341:1078-1087(2006). RN [7] RP SUBCELLULAR LOCATION, AND TOPOLOGY. RX PubMed=27086875; DOI=10.1016/j.bbamcr.2016.04.010; RA Hasegawa H., Patel N., Ettehadieh E., Li P., Lim A.C.; RT "Topogenesis and cell surface trafficking of GPR34 are facilitated by RT positive-inside rule that effects through a tri-basic motif in the first RT intracellular loop."; RL Biochim. Biophys. Acta 1863:1534-1551(2016). CC -!- FUNCTION: G-protein-coupled receptor of lysophosphatidylserine (LysoPS) CC that plays different roles in immune response (PubMed:16460680). Acts a CC damage-sensing receptor that triggers tissue repair upon recognition of CC dying neutrophils (By similarity). Mechanistically, apoptotic CC neutrophils release lysophosphatydilserine that are recognized by type CC 3 innate lymphoid cells (ILC3s) via GPR34, which activates downstream CC PI3K-AKT and RAS-ERK signaling pathways leading to STAT3 activation and CC IL-22 production (By similarity). Plays an important role in microglial CC function, controlling morphology and phagocytosis (By similarity). CC {ECO:0000250|UniProtKB:Q9R1K6, ECO:0000269|PubMed:16460680}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:27086875}; CC Multi-pass membrane protein {ECO:0000269|PubMed:27086875}. CC -!- TISSUE SPECIFICITY: Broadly expressed. Highly expressed on mast cells CC (PubMed:16460680). {ECO:0000269|PubMed:16460680}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF039686; AAD50531.1; -; mRNA. DR EMBL; AF118670; AAD17248.1; -; Genomic_DNA. DR EMBL; AK027780; BAB55362.1; -; mRNA. DR EMBL; BC020678; AAH20678.1; -; mRNA. DR CCDS; CCDS14258.1; -. DR RefSeq; NP_001091048.1; NM_001097579.1. DR RefSeq; NP_005291.1; NM_005300.3. DR RefSeq; XP_005272654.1; XM_005272597.3. DR PDB; 8K4N; EM; 2.83 A; D=49-327. DR PDB; 8SAI; EM; 3.27 A; A=38-373. DR PDB; 8WRB; EM; 2.91 A; R=1-344. DR PDBsum; 8K4N; -. DR PDBsum; 8SAI; -. DR PDBsum; 8WRB; -. DR AlphaFoldDB; Q9UPC5; -. DR EMDB; EMD-36887; -. DR EMDB; EMD-37771; -. DR EMDB; EMD-40270; -. DR SMR; Q9UPC5; -. DR BioGRID; 109115; 16. DR IntAct; Q9UPC5; 1. DR STRING; 9606.ENSP00000367384; -. DR BindingDB; Q9UPC5; -. DR ChEMBL; CHEMBL3562165; -. DR GuidetoPHARMACOLOGY; 101; -. DR GlyCosmos; Q9UPC5; 5 sites, No reported glycans. DR GlyGen; Q9UPC5; 5 sites. DR iPTMnet; Q9UPC5; -. DR PhosphoSitePlus; Q9UPC5; -. DR BioMuta; GPR34; -. DR DMDM; 12643337; -. DR jPOST; Q9UPC5; -. DR MassIVE; Q9UPC5; -. DR PaxDb; 9606-ENSP00000367384; -. DR PeptideAtlas; Q9UPC5; -. DR ProteomicsDB; 85365; -. DR Antibodypedia; 547; 331 antibodies from 30 providers. DR DNASU; 2857; -. DR Ensembl; ENST00000378138.5; ENSP00000367378.5; ENSG00000171659.16. DR Ensembl; ENST00000378142.9; ENSP00000367384.4; ENSG00000171659.16. DR Ensembl; ENST00000649219.1; ENSP00000498130.1; ENSG00000171659.16. DR GeneID; 2857; -. DR KEGG; hsa:2857; -. DR MANE-Select; ENST00000378142.9; ENSP00000367384.4; NM_001097579.2; NP_001091048.1. DR UCSC; uc004dfp.4; human. DR AGR; HGNC:4490; -. DR CTD; 2857; -. DR DisGeNET; 2857; -. DR GeneCards; GPR34; -. DR HGNC; HGNC:4490; GPR34. DR HPA; ENSG00000171659; Tissue enhanced (placenta). DR MIM; 300241; gene. DR neXtProt; NX_Q9UPC5; -. DR OpenTargets; ENSG00000171659; -. DR PharmGKB; PA28878; -. DR VEuPathDB; HostDB:ENSG00000171659; -. DR eggNOG; ENOG502QT81; Eukaryota. DR GeneTree; ENSGT01060000248589; -. DR InParanoid; Q9UPC5; -. DR OMA; IIHKCNE; -. DR OrthoDB; 3875139at2759; -. DR PhylomeDB; Q9UPC5; -. DR TreeFam; TF330969; -. DR PathwayCommons; Q9UPC5; -. DR SignaLink; Q9UPC5; -. DR SIGNOR; Q9UPC5; -. DR BioGRID-ORCS; 2857; 20 hits in 766 CRISPR screens. DR ChiTaRS; GPR34; human. DR GenomeRNAi; 2857; -. DR Pharos; Q9UPC5; Tchem. DR PRO; PR:Q9UPC5; -. DR Proteomes; UP000005640; Chromosome X. DR RNAct; Q9UPC5; Protein. DR Bgee; ENSG00000171659; Expressed in calcaneal tendon and 149 other cell types or tissues. DR ExpressionAtlas; Q9UPC5; baseline and differential. DR GO; GO:0005886; C:plasma membrane; TAS:ProtInc. DR GO; GO:0045028; F:G protein-coupled purinergic nucleotide receptor activity; IBA:GO_Central. DR GO; GO:0004930; F:G protein-coupled receptor activity; TAS:ProtInc. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central. DR CDD; cd15148; 7tmA_GPR34-like; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR048057; GPR34_7tmA. DR PANTHER; PTHR24233:SF1; G-PROTEIN COUPLED RECEPTOR 34-RELATED; 1. DR PANTHER; PTHR24233; P2Y PURINOCEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PRINTS; PR01157; P2YPURNOCPTR. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; Q9UPC5; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor; KW Glycoprotein; Membrane; Receptor; Reference proteome; Transducer; KW Transmembrane; Transmembrane helix. FT CHAIN 1..381 FT /note="Probable G-protein coupled receptor 34" FT /id="PRO_0000069559" FT TOPO_DOM 1..61 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 62..82 FT /note="Helical; Name=1" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 83..88 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 89..109 FT /note="Helical; Name=2" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 110..128 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 129..149 FT /note="Helical; Name=3" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 150..171 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 172..192 FT /note="Helical; Name=4" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 193..216 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 217..237 FT /note="Helical; Name=5" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 238..269 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 270..290 FT /note="Helical; Name=6" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 291..310 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:27086875" FT TRANSMEM 311..331 FT /note="Helical; Name=7" FT /evidence="ECO:0000269|PubMed:27086875" FT TOPO_DOM 332..381 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:27086875" FT CARBOHYD 28 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 36 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 42 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 200 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 295 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 127..204 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT CONFLICT 181 FT /note="L -> V (in Ref. 1; AAD50531)" FT /evidence="ECO:0000305" SQ SEQUENCE 381 AA; 43860 MW; 491FC016E5624379 CRC64; MRSHTITMTT TSVSSWPYSS HRMRFITNHS DQPPQNFSAT PNVTTCPMDE KLLSTVLTTS YSVIFIVGLV GNIIALYVFL GIHRKRNSIQ IYLLNVAIAD LLLIFCLPFR IMYHINQNKW TLGVILCKVV GTLFYMNMYI SIILLGFISL DRYIKINRSI QQRKAITTKQ SIYVCCIVWM LALGGFLTMI ILTLKKGGHN STMCFHYRDK HNAKGEAIFN FILVVMFWLI FLLIILSYIK IGKNLLRISK RRSKFPNSGK YATTARNSFI VLIIFTICFV PYHAFRFIYI SSQLNVSSCY WKEIVHKTNE IMLVLSSFNS CLDPVMYFLM SSNIRKIMCQ LLFRRFQGEP SRSESTSEFK PGYSLHDTSV AVKIQSSSKS T //